Literature DB >> 21665519

Scanning slit topography: diagnostic boon in presumed unilateral Terrien's marginal degeneration.

Merle Fernandes1.   

Abstract

PURPOSE: To describe the scanning slit topography in two children with presumed unilateral Terrien's marginal degeneration.
METHODS: Two girls aged 9 and 12 years presented with redness and reduced vision in their right eyes. The younger patient had scarring adjacent to the superior limbus, with vessels coursing across, and lipid deposition. Visual acuity improved to 20/20 from 20/400 with +1.0 -3.5×90°. The older patient had similar features inferiorly. Her visual acuity improved to 20/20 from 20/40 with -3.5×65°. Their left eyes were normal. A diagnosis of unilateral Terrien's Marginal Degeneration (TMD) was made.
RESULTS: Scanning slit topography (Orbscan II™, Orbscan Inc., Salt Lake City, UT) of the right eyes revealed high against-the-rule astigmatism. The left eyes showed elevations of anterior and posterior corneal surface above the best-fit-sphere, skewing of principal meridians and increased astigmatism from 3.0 to 5.0mm zones. Based on these findings bilateral asymmetric TMD was diagnosed.
CONCLUSION: Though the diagnosis of TMD is mainly clinical, scanning slit topography findings in TMD have not been described earlier and are useful in establishing the diagnosis of bilateral asymmetric TMD. 2011 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21665519     DOI: 10.1016/j.clae.2011.05.002

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  2 in total

1.  Patch Graft for Corneal Perforation Following Trivial Trauma in Bilateral Terrien's Marginal Degeneration.

Authors:  Merle Fernandes; Divya Vira
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

2.  Terrien's marginal degeneration accompanied by latticed stromal opacities.

Authors:  Yibing Zhang; Hui Jia
Journal:  Optom Vis Sci       Date:  2014-05       Impact factor: 1.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.